Standout Papers

Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19 2020 2026 2022 2024321
  1. Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19 (2020)
    Eric J. Lenze, Caline Mattar et al. JAMA

Immediate Impact

57 standout
Sub-graph 1 of 23

Citing Papers

The interaction of innate immune and adaptive immune system
2024 Standout
Three-year outcomes of post-acute sequelae of COVID-19
2024 Standout
2 intermediate papers

Works of Julia Schweiger being referenced

Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19
2020 Standout

Author Peers

Author Last Decade Papers Cites
Julia Schweiger 416 120 115 243 212 23 1.0k
H. Oberbauer 445 86 66 131 284 17 1.1k
Robert Malcolm 252 136 140 78 132 24 1.3k
Peter S. Mueller 239 85 50 111 192 34 1.0k
Chun-Hsin Chen 408 137 87 213 236 51 1.2k
Daniel Kopf 217 77 83 386 271 72 1.3k
Stanley Slater 160 174 90 128 89 31 1.0k
Chiara C. Bortolasci 290 136 84 62 173 62 1.4k
David D. Kim 264 136 112 141 284 58 1.3k
Padideh Ghaeli 400 195 137 115 123 75 1.2k
Paul Ragan 150 109 200 75 110 19 1.3k

All Works

Loading papers...

Rankless by CCL
2026